How I Treat Aggression in Outpatients With Dementia. C. Omelan MD, FRCP(C)

Size: px
Start display at page:

Download "How I Treat Aggression in Outpatients With Dementia. C. Omelan MD, FRCP(C)"

Transcription

1 How I Treat Aggression in Outpatients With Dementia C. Omelan MD, FRCP(C)

2 Conflict of Interest I have no potential conflicts of interest to declare

3 Overview Outline the prevalence of aggression Review management of responsive beh s Non-pharmacologic pharmacologic Discuss resources for family MD s Discussion/questions

4 Prevalence Of Aggression Community (%) 1 Nursing home (%) 2 Care facilities (%) 3 Overall prevalence Clinically significant Delusions Hallucinations Depressed mood Activity disturbance Aggression/agitation (aggression only) 42 (total agitation) Apathy Lyketsos CG et al. Am J Psychiatry 2000; 157: Brodaty H et al. Int J Geriatr Psychiatry 2001; 16: Ballard C et al. J Clin Psychiatry 2001; 62: 631 6

5 NPS Clusters Apathy Withdrawn Lack of interest Amotivation Aggression Aggressive resistance Physical aggression Verbal aggression Depression Sad Tearful Hopeless Low self-esteem Anxiety Guilt Psychosis Hallucinations Delusions Misidentifications Agitation Walking aimlessly Pacing Trailing Restlessness Repetitive actions Dressing/undressing Sleep disturbance McShane R. Int Psychogeriatr 2000; 12 (Suppl 1):

6 From Gauthier & Thal, 1999

7 Aggression Verbal threats Physical striking-out Often targeted against spouse or family May precipitate an ER visit or hospitalization

8 What Aggression Means... A opportu ity has usua y bee missed The sweet spot for relocating has come & gone Aggression occurring in the community generally makes placement more difficu t

9 Approach to Behavioral Issues Ask ho has the prob em? Ask ho da gerous is the behavior (rather than ho a oyi g) Concentrate on those behaviours which affect safety

10 Approach to Behavioral Issues Identify possible precipitants e.g.spouse s communication style Think about u met eeds Try non-pharmacologic interventions first Reserve medications for when behavior is u safe

11 Approach to Behavioral Issues If emerge t safety issues: call the Mobile Crisis Team or have family pursue a warrant for exam (FORM 1) through the magistrate

12

13 GMHT If non-emergent, consider consulting the GMHT Open referral through central intake Not a crisis service Can provide an in-home assessment Have tip sheets regarding aggression or improving communication

14

15 Non-Pharm Interventions Proven effective for severe agitation: Me ta hea th assessme t (e.g. GMHT) Exercise Se sory stimu atio Commu icatio ski s trai i g staff & fami y Care mappi g Schedu ed p easa t activities Livingston G. The British Journal of Psychiatry (2014) 205,

16 Alzheimer Society Provides caregiver support & educatio groups Enhanced programs with additional expertise as required Have o i e resources available Special groups for you ger o set deme tia (teleconference & in person)

17 Drug Therapy Drugs used for aggressive behaviors in dementia have limited benefits and significant side effects

18 Can Fam Physician 2006;52:

19 Drug Therapy Only ~18% of pts respond to a given antipsychotic Schneider, LS. et al. JAGS 1990;38: 553. Medications increase falls & hip # Major tranquilizers double the risk of death in demented pts ~1% absolute death rate increase in 8-12 weeks Schneider LS. et al JAMA. 2005; 294(15):

20 Drug Related Mortality Compared with matched nonusers, pts receiving: haloperidol had an d mortality risk of 3.8% (95% CI, 1.0% 6.6%; P <.01) NNH of 26 for 1 excess death/year (95% CI, 15 99) risperidone, d mortality risk of 3.7% (95% CI, 2.2% 5.3%; P <.01) NNH of 27 for 1 excess death/year (95% CI, 19 46) Maust DT. JAMA Psychiatry May 1; 72(5):

21 CCCD (2012) Recommendations Risperido e, o a zapi e and aripiprazo e be used for severe agitation, aggression and psychosis associated with dementia where there is risk of harm to the patient and/or others. The potential benefit of all antipsychotics must be weighed against the significant risks, such as cerebrovascular adverse events and mortality. (Grade 2A) Hermann N. Alz Research & Therapy 2013;5(suppl):55

22 Antidepressants CCCD (2012) concluded: There is insufficient evidence to recommend for or agai s the use of SSRI s or trazodone in the management of agitated patients. (Grade 2B) Hermann N. Alz Research & Therapy 2013;5(suppl):55

23 Trazodone Citalopram Risperidone Quetiapine* Occasionally: Gabapentin* Valproic Acid* Prazosin* Dextromethorphan* Olanzapine Methotrimeprazine* Medications I Use * limited RCT evidence

24 How Long To Treat? Numerous studies have shown that antipsychotics can later be withdrawn ithout cha ge i behaviour Ballard et al J.Clin Psych 2004; 65:

25

26 Take Home Points Ask: Who eeds treatment? Use behavioral & environ l interventions first Reserve Rx for behaviors which pose a safety risk or marked distress I generally use non-neuroleptics first trazodone, citalopram, prazosin

27 Antipsychotic Take Home Points Ask: Who needs to stay on tx? Use lowest effective dose for shortest possib e time

28 Resources for Primary Care Geriatric Mental Health Teams (GMHT) through WRHA central intake In community or PCH Psychiatric consultation is available Community-living patients may be referred to SBGH Outpatient department

29 Resources for Primary Care Transitional panel for behavioral issues Behaviour units at Tache Riverview DLC

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs Across the Spectrum of Dementia Keys to Understanding Behaviours & Anticipating Needs Outline Review current predictions for dementia prevalence, & the implications for future needs Discuss retrogenesis

More information

11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease

11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease Disclosures Behavioral Management of Persons with Alzheimer s Disease Wisconsin Association of Medical Directors November 17, 2016 Art Walaszek, M.D. Professor of Psychiatry UW School of Medicine & Public

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4 Management of Agitation in Dementia Kimberly Triplett Ferguson, MS4 Objectives 1. Review recommended evaluation of agitated patients with dementia. 2. Discuss evidence concerning nonpharmacologic management.

More information

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehab Institute, UHN Learning objectives Recognize

More information

Neuropsychiatric Syndromes

Neuropsychiatric Syndromes Neuropsychiatric Syndromes Susan Czapiewski,MD VAHCS December 10, 2015 Dr. Czapiewski has indicated no potential conflict of interest to this presentation. She does intend to discuss the off-label use

More information

Antipsychotic Medications

Antipsychotic Medications TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood

More information

Behaviour Units: Understanding what they can offer Older Patients with Dementia

Behaviour Units: Understanding what they can offer Older Patients with Dementia Behaviour Units: Understanding what they can offer Older Patients with Dementia David K. Conn Baycrest Centre and University of Toronto 2013 Mount Sinai Geriatrics institute Outline Alice s journey continues

More information

Management of the Acutely Agitated Long Term Care Patient

Management of the Acutely Agitated Long Term Care Patient Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia

More information

Behavioral and Psychological Symptoms of dementia (BPSD)

Behavioral and Psychological Symptoms of dementia (BPSD) Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management

More information

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M. ISSNISSN ISSN: 2456-3927 NeuroPharmac Journal Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M. Alshahrani www. neuropharmac.com Jan-April 2018, Volume 3, Issue

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL DID YOU KNOW THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL. Did you know that it is essential to know the target cluster(s)/symptom(s) one is treating to guide and monitor non-pharmacological approaches and pharmacological

More information

Treatment of behavioral and psychological symptoms of dementia: a systematic review

Treatment of behavioral and psychological symptoms of dementia: a systematic review Psychiatr. Pol. 2016; 50(4): 679 715 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/pp/64477 Treatment of behavioral and psychological symptoms

More information

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital with thanks to Jonathan Cavan for his input Aims Define BPSD and common symptoms

More information

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed

More information

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA Unmet needs What might be your behavioural response to this experience? Content Definition What are BPSD? Prevalence How common are they? Aetiological

More information

How Aging and Dementia Effect Resident Behaviors

How Aging and Dementia Effect Resident Behaviors How Aging and Dementia Effect Resident Behaviors November 3, 2011 1:00 2:00 PM EST Webinar Presented by: Alfred W. Norwood, BS, MBA Education Arm of the Carmelite Sisters for the Aged and Infirm Webinar

More information

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia

More information

Management of Behavioral Problems in Dementia

Management of Behavioral Problems in Dementia Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of

More information

MANAGEMENT OF NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA

MANAGEMENT OF NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA MANAGEMENT OF NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA Dr. Dallas Seitz MD PhD FRCPC Associate Professor and Division Chair, Division of Geriatric Psychiatry Department of Psychiatry, Queen s University President,

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017

More information

Psychosis and Agitation in Dementia

Psychosis and Agitation in Dementia Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University

More information

What Can Geriatrics Teach Us About the Care of Vulnerable Patients?

What Can Geriatrics Teach Us About the Care of Vulnerable Patients? What Can Geriatrics Teach Us About the Care of Vulnerable Patients? Helen Kao MD Associate Professor Medical Director, UCSF Geriatrics Clinical Programs UCSF March 11, 2016 Objectives 1. Define vulnerabilities

More information

Pharmacological Treatment of Aggression in the Elderly

Pharmacological Treatment of Aggression in the Elderly Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question

More information

Pharmacologyonline 1: (2009) ewsletter Rosanna Erra. Atypical Antipsychotic Drugs for the Treatment of BPSD. in Subjects with Dementia

Pharmacologyonline 1: (2009) ewsletter Rosanna Erra. Atypical Antipsychotic Drugs for the Treatment of BPSD. in Subjects with Dementia Atypical Antipsychotic Drugs for the Treatment of BPSD in Subjects with Dementia Rosanna Erra School of Pharmacy, University of Salerno, Italy ros.erra@libero.it Summary Behavioural and psychological disorders

More information

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE KRISTA L. LANCTÔT, PHD PROFESSOR OF PSYCHIATRY AND PHARMACOLOGY, UNIVERSITY OF TORONTO; SENIOR SCIENTIST, HURVITZ BRAIN

More information

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director Older People Mental Health - new directorate/new plans Dr Adrian Treloar Clinical director Dementia 700,000 people in the UK currently have dementia; this number is set to double by 2038 1/3 of people

More information

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer

More information

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE? USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE? Mugdha Thakur, MD Associate Professor of Psychiatry and Behavioral Sciences Duke University

More information

Negative Symptoms of Schizophrenia: Treatments

Negative Symptoms of Schizophrenia: Treatments Negative Symptoms of Schizophrenia: Treatments Nowadays we tend to think of the various symptoms of schizophrenia as falling into two groups. There are the positive symptoms such as delusions and hallucinations

More information

Psychotropic Strategies Handout Package

Psychotropic Strategies Handout Package Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles

More information

Lewy Body Disease. Dementia Education for the First Responder July 27, 2017

Lewy Body Disease. Dementia Education for the First Responder July 27, 2017 Lewy Body Disease Dementia Education for the First Responder July 27, 2017 Dylan Wint, M.D. NV Energy Chair for Brain Health Education Cleveland Clinic Lou Ruvo Center for Brain Health OUTLINE Lewy body

More information

Caregiver Mediated Intervention. Trumps Pharmacotherapy for BPSD

Caregiver Mediated Intervention. Trumps Pharmacotherapy for BPSD Caregiver Mediated Intervention DEMENTIA RESEARCH Trumps Pharmacotherapy for BPSD Henry Brodaty and Caroline Arasaratnam Dementia Collaborative Research Centre Assessment and Better Care Collaborative

More information

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? STEPHANIE M. OZALAS, PHARMD, BCPS, BCGP VA MARYLAND HEALTH CARE SYSTEM BALTIMORE, MD DISCLOSURES Off-label use of medications will be

More information

Managing Behavioural Problems in Patients with Dementia in LTC and at Home

Managing Behavioural Problems in Patients with Dementia in LTC and at Home Managing Behavioural Problems in Patients with Dementia in LTC and at Home Disclosures I have received various speaking honourarium Celgene NS Department of Transportation and Infrastructure Renewal Samuel

More information

Managing Behavioural Problems in Patients with Dementia in LTC and at Home

Managing Behavioural Problems in Patients with Dementia in LTC and at Home Managing Behavioural Problems in Patients with Dementia in LTC and at Home Samuel D. Searle MD, FRCPC Assistant Professor Division of Geriatric Medicine Dalhousie University Disclosures I have received

More information

Dementia: Managing Difficult Behaviors. No conflicts of interest. Off-label medication use will be discussed during this talk.

Dementia: Managing Difficult Behaviors. No conflicts of interest. Off-label medication use will be discussed during this talk. Dementia: Managing Difficult Behaviors No conflicts of interest. Off-label medication use will be discussed during this talk. 1 Types of Neurocognitive Disorder Alzheimer s Disease Vascular Frontotemporal

More information

An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E.

An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E. An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E. Fisher Background Disease. (Xu, Kochanek & Tejada-Vera, 2009)

More information

HDSA welcomes you to Caregiver s Corner. Funded by an educational grant from

HDSA welcomes you to Caregiver s Corner. Funded by an educational grant from HDSA welcomes you to Caregiver s Corner Funded by an educational grant from Caregiver s Corner Webinar, DATE Managing Psychiatric Symptoms Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics

More information

WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by

WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together Presented by Our agenda for today Understanding behavioral symptoms in people living with dementia Briefly review key strategies

More information

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

9/24/2012. Amer M Burhan, MBChB, FRCP(C) Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression

More information

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Professor Clive Ballard Dr Byron Creese University of Exeter, UK Guardian guide for 2018: Top

More information

Telepsychiatry In Rural Nursing Homes

Telepsychiatry In Rural Nursing Homes Telepsychiatry In Rural Nursing Homes Andrew Rosenzweig MD, MPH Chief Medical Officer, Forefront TeleCare Assistant Clinical Professor, Brown University cope of Problem: evere Unmet Need Over 5,000 rural/hpa

More information

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Pharmacological Management of Dementia-Related Behaviors

Pharmacological Management of Dementia-Related Behaviors Welcomes You To Pharmacological Management of Dementia-Related Behaviors Presented by Brett Lu, MD, PhD Associate Professor of Psychiatry John A. Burns School of Medicine September 5, 2017 10:00 11:00

More information

2/9/2018. Certificate of Completion: Pharmacological Management of Dementia Related Behaviors. Welcomes You To

2/9/2018. Certificate of Completion: Pharmacological Management of Dementia Related Behaviors. Welcomes You To Welcomes You To Pharmacological Management of Dementia Related Behaviors Presented by Brett Lu, MD, PhD Associate Professor of Psychiatry John A. Burns School of Medicine September 5, 2017 10:00 11:00

More information

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES CHCS Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia December 2010 Cynthia Boyd, MD, MPH* Bruce Leff, MD* Carlos

More information

Medication alternatives for behavioural disturbance

Medication alternatives for behavioural disturbance Neurology 13 Medication alternatives for behavioural disturbance Many patients with dementia will in the later stages develop distressing behavioural symptoms. Antipsychotics are commonly used to treat

More information

Delirium. Approach. Symptom Update Masterclass:

Delirium. Approach. Symptom Update Masterclass: Symptom Update Masterclass: Delirium Jason Boland Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine Wolfson Centre for Palliative Care Research Hull York Medical School University

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

Alzheimer Society & our First Link Program

Alzheimer Society & our First Link Program Alzheimer Society & our First Link Program Overview of Presentation Visio a d Missio of the A zheimer Society What is Deme tia? A zheimer Society Programs a d Services & our First Li k Program Too s a

More information

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital October 28, 2016 Geriatrics Update Course Managing BPSD Lesley Wiesenfeld, MD, MHCM, FRCPC Geriatric Psychiatrist, Mount Sinai Hospital Disclosures ~No Pharmaceutical or Industry Support ~ No Health Without

More information

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D. Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS

More information

Antipsychotics in Dementia

Antipsychotics in Dementia Antipsychotics in Dementia What s all the fuss? Judy MacDonald RPh BSc Pharm Dr. Ashok Krishnamoorthy MD MRCPsych FRCPC ABAM MS (Neuro Psych) Learning Objectives Recognize common behavioural & psychological

More information

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS A REALITY CHECK reality check Noun informal an occasion on which one is reminded of the state of things in the real world. ROBERT LACOSTE, MD MEDICAL DIRECTOR,

More information

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Professor Tony Holland, Department of Psychiatry, University of Cambridge INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with

More information

Drugs used to relieve behavioural and psychological symptoms in dementia

Drugs used to relieve behavioural and psychological symptoms in dementia alzheimers.org.uk Drugs used to relieve behavioural and psychological symptoms in dementia People with dementia may develop behavioural and psychological symptoms including restlessness, aggression, delusions,

More information

Assessment and management of behavioral and psychological symptoms of dementia

Assessment and management of behavioral and psychological symptoms of dementia Assessment and management of behavioral and psychological symptoms of dementia Helen C Kales, 1 2 3 Laura N Gitlin, 4 5 6 Constantine G Lyketsos 7 1 Section of Geriatric Psychiatry, Department of Psychiatry,

More information

Up to 90% of people with dementia experience

Up to 90% of people with dementia experience Focus on CME at the University of Calgary Getting Aggressive with Dementia Adrienne Cohen, MD, BSc, FRCPC Presented at Behaviour Problems in the Elderly, video-audio conference, 2003 Up to 90% of people

More information

Geriatric Grand Rounds. Managing Behavioural and Psychological Symptoms of Dementia (BPSD) in Patients with Alzheimer s Disease

Geriatric Grand Rounds. Managing Behavioural and Psychological Symptoms of Dementia (BPSD) in Patients with Alzheimer s Disease Geriatric Grand Rounds Visit web sites: Tuesday, April 14, 2009 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF

More information

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center Medications and Non-Pharma Approaches to Treatment David J. Irwin, MD Penn Frontotemporal Degeneration Center Outline Non-Pharmacological Treatment Strategies Behavior Language Motor Supportive Care Check-points

More information

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Professor Tony Holland, Department of Psychiatry, University of Cambridge INFORMATION SHEET The Use of Medication in the Treatment of Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction The use of medication is but one

More information

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics Cognitive enhancers PINCH ME Anticholinergic burden BPSD Agitation, Aggression and antipsychotics 2 types Cholinesterase inhibitors licensed for mild to moderate AD Donepezil Galantamine Rivastigmine also

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

GERIATRIC WORKFORCE ENHANCEMENT PROGRAM (GWEP) FACULTY DEVELOPMENT MASTERWORKS SERIES

GERIATRIC WORKFORCE ENHANCEMENT PROGRAM (GWEP) FACULTY DEVELOPMENT MASTERWORKS SERIES UNIVERSITY OF SOUTH FLORIDA GERIATRIC WORKFORCE ENHANCEMENT PROGRAM (GWEP) FACULTY DEVELOPMENT MASTERWORKS SERIES Kathryn Hyer, PhD, MPP Principal Investigator h Providers of Continuing Education For additional

More information

Mental Health & Your Teen Tools, Strategies & Resources

Mental Health & Your Teen Tools, Strategies & Resources 3 rd Annual 22q11DS Family Conference Mental Health & Your Teen Tools, Strategies & Resources Dr. Claire De Souza Child & Adolescent Psychiatrist Medical Director, Consultation-Liaison Psychiatry Program

More information

Antipsychotics for Dementia Under Control or Over-Prescribed?

Antipsychotics for Dementia Under Control or Over-Prescribed? Antipsychotics for Dementia Under Control or Over-Prescribed? Nathaniel Hedrick, PharmD ProCare HospiceCare, Manager of Clinical Services Learning Objectives Summarize the disease progression and most

More information

Vanderbilt & Qsource Webinar Series

Vanderbilt & Qsource Webinar Series Vanderbilt & Qsource Webinar Series Vanderbilt Medical Center Vanderbilt University Center for Quality Aging Qsource Session #1: Introduction to Dementia Care & QAPI Session #2: Dementia & Behavioral Disturbances

More information

Palliative Care Consult Service

Palliative Care Consult Service Creating Program Elements to Improve the Care of the Dementia Patient in Palliative & Hospice Settings Carla Jolley MN, ARNP, ANP-BC, AOCN, ACHPN Palliative Care APN/Program Coordinator WhidbeyHealth Palliative

More information

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018 Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018 Mary Ellen Quiceno, MD, FAAN Associate Professor of Neurology UNTHSC Center for Geriatrics 855 Montgomery Street, PCC 4, Ft.

More information

Recognizing Pain in People with Dementia

Recognizing Pain in People with Dementia Recognizing Pain in People with Dementia CAT H Y CIOLEK, D PT, FA PTA B O A R D C E R T I F I E D G E R I AT R I C C L I N I C A L S P E C I A L I S T C E R T I F I E D D E M E N T I A P R A C T I T I

More information

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario SECTION 1 Children and Adolescents with Depressive Disorder: Summary of Findings from the Literature and Clinical Consultation in Ontario Children's Mental Health Ontario Children and Adolescents with

More information

Managing agitation in dementia using non-pharmacological therapies

Managing agitation in dementia using non-pharmacological therapies Managing agitation in dementia using non-pharmacological therapies Gill Livingston Lynsey Kelly, Elanor Lewis-Holmes, Gianluca Baio, Rumana Omar, Stephen Morris, Nishma Patel, Cornelius Katona, Claudia

More information

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac

More information

DEMENTIA AND MEDICATION

DEMENTIA AND MEDICATION DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,

More information

Mental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL)

Mental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL) Mental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL) Multidimensional concept Includes: Physical health Cognitive

More information

Mental Health Issues in Nursing Homes. I m glad you asked.

Mental Health Issues in Nursing Homes. I m glad you asked. Mental Health Issues in Nursing Homes I m glad you asked. I m glad you asked Susan Wehry, M.D. Associate Professor of Psychiatry, College of Medicine, University of Vermont Consultant, State of Vermont

More information

11/11/2016. Relevant Disclosures Current or past. Outline

11/11/2016. Relevant Disclosures Current or past. Outline Management of Agitation in Dementia 2016 Update Constantine G. Lyketsos, MD, MHS Interim Chair of Psychiatry, Johns Hopkins Medicine Elizabeth Plank Althouse Professor, Johns Hopkins University kostas@jhmi.edu

More information

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment

More information

Parkinsonian Disorders with Dementia

Parkinsonian Disorders with Dementia Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University

More information

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Management of Behavioral Symptoms in Dementia Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Behavioral Symptoms Common & troubling At least one will occur in 61-92% of those with any dementia

More information

A Basic Approach to Mood and Anxiety Disorders in the Elderly

A Basic Approach to Mood and Anxiety Disorders in the Elderly A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict

More information

An#psycho#c Medica#on in People with Demen#a

An#psycho#c Medica#on in People with Demen#a An#psycho#c Medica#on in People with Demen#a GERARD BYRNE BSc (Med), MBBS (Hons), PhD, FRANZCP, MFPOA School of Medicine, University of Queensland Mental Health Service, Royal Brisbane & Women s Hospital

More information

Introduction to Dementia: Complications

Introduction to Dementia: Complications Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:

More information

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,

More information

Behavioural Problems and Patterns of Psychopharmacological Treatment given in Elderly Patients with Dementia

Behavioural Problems and Patterns of Psychopharmacological Treatment given in Elderly Patients with Dementia The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 6, Issue 4, DIP: 18.01.090/20180604 DOI: 10.25215/0604.090 http://www.ijip.in October-December, 2018 Research

More information

Dementia Training Session for Carers. By Dr Rahul Tomar Consultant Psychiatrist

Dementia Training Session for Carers. By Dr Rahul Tomar Consultant Psychiatrist Dementia Training Session for Carers By Dr Rahul Tomar Consultant Psychiatrist Dementia in the UK: Facts & Figures National Dementia strategy launched in 2009 800,000 people living with dementia (2012)

More information

Assessing and Treating Agitation Associated with Alzheimer s Disease

Assessing and Treating Agitation Associated with Alzheimer s Disease AXS-05 R&D Day April 24, 2018 Assessing and Treating Agitation Associated with Alzheimer s Disease Marc E. Agronin, MD VP, Behavioral Health and Clinical Research, Miami Jewish Health Affiliate Associate

More information

Dementia A syndrome, not a disease. Mordechai Lavi, MD Geriatric Physician

Dementia A syndrome, not a disease. Mordechai Lavi, MD Geriatric Physician Dementia A syndrome, not a disease Mordechai Lavi, MD Geriatric Physician Objectives 1. To improve our understanding of how we diagnose a dementia syndrome 2. Understand the workup that should be expected

More information

Affective Disorders.

Affective Disorders. Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders

More information

The burden of psychotropic drug prescribing in people with dementia: a population database study

The burden of psychotropic drug prescribing in people with dementia: a population database study Age and Ageing 2010; 39: 637 642 doi: 10.1093/ageing/afq090 Published electronically 12 July 2010 The Author 2010. Published by Oxford University Press on behalf of the British Geriatrics Society. All

More information